Articles

The U.S.-China agreement to reduce reciprocal tariffs “likely [takes] a recession off the table for now,” Wedbush analysts said.

With U.S. economic growth turning negative during the first quarter, this earnings season’s results might shed some light on which companies may best weather the disruption brought about by President Donald Trump’s “liberation day” tariffs announced on April 2.

“I don’t have time to work a second job. I am on call, and I also do not have child care.”

The consumer-discretionary sector is particularly sensitive to soft consumer demand and tariff-fueled macroeconomic uncertainty.

With the prospect of more favorable tariff terms between the two key trading partners, investors are betting that increased economic activity will boost financial activity.

One glance at BofA’s currency and rates sentiment survey would have indicated a sharp reversal was imminent in the event of any positive macro developments.

UBS strategists led by Sean Simonds have a timely note about how now the questions will be less on policy uncertainty and more on outcome uncertainty.

“I don’t mind paying for all or part of the bill. We can afford that and, honestly, it’s nice to get double or triple credit-card points for eating out.”

A study of two blockbuster weight-loss drugs came out in favor of Eli Lilly over its rival Novo Nordisk.

U.S. stocks have underperformed their European rivals this year — and strategists at JPMorgan say it’s just the start.

The U.S. Trade Secretary Scott Bessent said neither the U.S. nor China want to see a decoupling in their relationship, as each agree to lower tariffs for 90 days.

President Donald Trump on Sunday said he will sign an executive order to slash prescription-drug prices.